This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Laboratories Cyclopharma, National Institute of Health and Medical Research. Active years: 2015.
Company Filing History:
1 out of 8,819 
1 out of 1 
1 out of 1,853 
Years Active: 2015
Title: Bertrand Kuhnast: Innovator in Radiopharmaceuticals
Introduction
Bertrand Kuhnast is a notable inventor based in Orsay, France, recognized for his contributions to the field of radiopharmaceuticals. His work focuses on the development of innovative compounds that have significant applications in medical imaging and therapy.
Latest Patents
Kuhnast holds a patent for "Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors." This invention relates to a specific compound that is utilized in pharmaceutical compositions for diagnostic purposes, particularly in SPECT or PET imaging. Additionally, it has therapeutic applications in the treatment of melanoma through targeted radionuclide therapy.
Career Highlights
Throughout his career, Bertrand Kuhnast has worked with prestigious institutions, including the Institut National de la Santé et de la Recherche Médicale and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these organizations has contributed to his expertise in the development of radiopharmaceuticals.
Collaborations
Kuhnast has collaborated with notable professionals in his field, including Jean-Michel Chezal and Frederic Dolle. These partnerships have enhanced his research and innovation efforts.
Conclusion
Bertrand Kuhnast's work in the field of radiopharmaceuticals exemplifies the impact of innovative research on medical diagnostics and treatment. His contributions continue to advance the understanding and application of multimodal radiopharmaceuticals.